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Background—Patient-centered health care interventions, such as heart failure disease management programs, are under
increasing pressure to demonstrate good value. Variability in costing methods and assumptions in economic evaluations
of such interventions limit the comparability of cost estimates across studies. Valid cost estimation is critical to
conducting economic evaluations and for program budgeting and reimbursement negotiations.
Methods and Results—Using sound economic principles, we developed the Tools for Economic Analysis of Patient
Management Interventions in Heart Failure (TEAM-HF) Costing Tool, a spreadsheet program that can be used by
researchers and health care managers to systematically generate cost estimates for economic evaluations and to
inform budgetary decisions. The tool guides users on data collection and cost assignment for associated personnel,
facilities, equipment, supplies, patient incentives, miscellaneous items, and start-up activities. The tool generates
estimates of total program costs, cost per patient, and cost per week and presents results using both standardized
and customized unit costs for side-by-side comparisons. Results from pilot testing indicated that the tool was
well-formatted, easy to use, and followed a logical order. Cost estimates of a 12-week exercise training program
in patients with heart failure were generated with the costing tool and were found to be consistent with estimates
published in a recent study.
Conclusions—The TEAM-HF Costing Tool could prove to be a valuable resource for researchers and health care managers
to generate comprehensive cost estimates of patient-centered interventions in heart failure or other conditions for
conducting high-quality economic evaluations and making well-informed health care management decisions. (Circ
Cardiovasc Qual Outcomes. 2012;5:113-119.)
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Patient-centered health care interventions, such as heartfailure disease management programs, are under increas-
ing pressure to demonstrate good value as health care budgets
are further scrutinized for inefficiency. High-quality cost
estimates are important to health care managers for budgetary
decision-making, setting payment rates, negotiating reim-
bursement contracts, forecasting costs with program expan-
sion or contraction, and identifying ways to improve program
efficiency. In research settings, there is also a growing
demand for economic evaluations that provide accurate and
standardized cost estimates so that national and international
bodies, professional societies, and managed care organiza-
tions can make informed guidelines and recommendations.1–7
The general lack of detail regarding cost-estimation meth-
ods in published studies of patient-focused interventions such
as cardiac rehabilitation, disease management interventions,
and other programs targeting patients with chronic conditions
suggests that there has been little standardization of costing
methods.8–19 The available information suggests that program
costs are systematically underestimated. Some studies report
on savings induced by the programs but do not include the
cost of the intervention,20–22 and others limit cost estimation
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WHAT IS KNOWN
● Published economic evaluations of disease manage-
ment programs apply a variety of approaches to cost
estimation, making comparisons across studies
difficult.
● High-quality, comprehensive cost estimates are es-
sential for informed decision making about program
budgeting, negotiating payments for services, and
conducting cost-effectiveness analyses to evaluate
the value of patient-centered interventions.
WHAT THE STUDY ADDS
● We developed the Tools for Economic Analysis of
Patient Management Interventions in Heart Failure
Costing Tool for use by research groups and health
care managers to estimate costs of patient-focused
programs.
● The tool facilitates data collection and cost estima-
tion for personnel, facilities, equipment, supplies,
patient incentives, miscellaneous items, and start-up
activities.
● Adoption of the tool and systematic reporting of
resulting cost estimates would lead to the availability
of standardized cost estimates across different types
of patient-focused interventions for heart failure or
other conditions.
to personnel time devoted to providing the intervention
without consideration of overhead or other fixed or variable
costs.9,13–15 Some analysts have applied reimbursement rates
for similar services as a proxy,23 and some have applied fees
paid to or charges from the companies that provide the
intervention.24–26 Although the latter strategy may represent
the appropriate cost from the payer’s perspective, this strat-
egy may lead to poor decision-making by the provider or
broader national decision-making bodies, because fees or
charges can misrepresent the resources actually devoted to
the intervention.27,28
Much of the literature has focused on heart failure, for
which expenditures are massive.29 More than 4 million
Medicare beneficiaries have heart failure, and more than
one-quarter of patients with heart failure die within 1 year.30
With more than 60% of expenditures attributable to inpatient
care,29 providers have long recognized the potential economic
savings of programs designed to reduce hospital admissions
among patients with heart failure.
Tools for Economic Analysis of Patient Management
Interventions in Heart Failure (TEAM-HF) consists of 2
projects. The first project is the development of a costing tool
designed to assist with estimating costs of patient-focused
interventions in heart failure or other conditions. The second
project aims to develop a customizable computer model to
estimate the long-term cost-effectiveness of patient-focused
interventions in heart failure. In this article, we report on the
development of the first project, the TEAM-HF Costing Tool.
We then compare estimates of the cost of an exercise training
program for patients with heart failure patients derived from
the costing tool with cost estimates reported in a recently
published economic evaluation of exercise training.9 Last, we
describe the potential uses of the tool and discuss its strengths
and limitations.
Methods
Determining the cost of a medical intervention requires consideration
of the study perspective and time horizon. The study perspective is
critical for determining which resources should be included and how
they should be valued.27,28 A study can take one or multiple
perspectives, depending on the objectives of the study. The societal
perspective is generally recommended, but other perspectives, such
as payer, patient, and provider, may also be of interest. If an
economic evaluation (eg, cost comparison, cost-effectiveness analy-
sis) is performed from the societal perspective, all resources incurred
in the delivery of the intervention should be included. In a clinic-
based disease management program, these resources include time for
all personnel involved directly or indirectly (eg, administrative staff)
in the delivery and maintenance of the program, supplies and
equipment used, facilities (for personnel or patients), and any
incentives, materials, and transportation services provided to patients
(or caregivers) enrolled in the program. With a societal perspective,
patients’ and caregivers’ time associated with the program should
also be incorporated, including time spent participating in the
program and time spent adhering to interventions associated with
program.27,31
To determine how fixed costs are handled requires determination
of the time horizon of interest. Time horizon can be classified into
short and long, depending on how costs for various resources may
change over time and with potential changes in volume. In the short
run, costs of administration (eg, support personnel) and capital (eg,
facilities, equipment) may be considered fixed costs in that costs for
these resources may not be expected to change in the near term or
increase to a significant degree with the initiation of a small disease
management program. That does not mean, however, that these costs
are zero. Over the long run or with growth in the numbers of patients
participating in the program, administrative and facility costs would
be expected to change and should be allocated to the cost of the
program.32
On identification of resources involved, each must be measured or
estimated. With a societal perspective, each of these resources should
then be valued at their opportunity cost, which is defined as the value
of the resource in its next best use. The economic concept of
opportunity cost promotes standardization across interventions and
allows for a fair comparison of resources necessary to carry out
different types of programs and treatments. Market prices typically
provide a good approximation of the opportunity cost for a resource.
In health care, however, prices (ie, charges) are sometimes inflated
well beyond the opportunity cost necessary to deliver a given
service, and adjustments or other sources of unit costs are necessary.
However, from the perspective of a payer, charges are relevant, and,
from the perspective of a provider, accounting costs (ie, the amount
paid for the resources) are appropriate.
Development Process
In developing the TEAM-HF Costing Tool, we wished to design a
user-friendly spreadsheet program that would facilitate the system-
atic identification, enumeration, and valuation of resources involved
in the provision of patient-centered health care interventions (eg,
disease management programs, skills coping training, exercise train-
ing, home-based care). Ultimately, we aimed to increase the validity
and reliability of estimated program costs used in published eco-
nomic evaluations to increase comparability across studies for
higher-quality decision-making. We recognized, however, that to
maximize the utility of the instrument for a wide range of users, the
instrument had to be designed to derive cost estimates that could
represent the different study perspectives discussed above. We also
sought to develop a tool that could account for costs incurred by
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different types of programs, in various settings, and for various
health conditions.
Throughout a series of drafts, we obtained feedback from an
expert advisory panel consisting of 2 academic nurse researchers, a
community-based nurse practitioner with expertise in disease man-
agement programs, a health economist, an academic cardiologist,
and a health policy expert.
Structure of the TEAM-HF Costing Tool
The TEAM-HF Costing Tool consists of a series of worksheets. The
“Overview” worksheet provides written documentation regarding the
features and methods applied in the costing tool. The second
worksheet, “Description and Costing Options,” classifies the type of
patient-focused program being assessed and the options available for
cost estimation. There are 2 worksheets representing different
strategies for deriving personnel costs and 1 worksheet for each of
the following types of resources: facilities, equipment, supplies/
incentives, and miscellaneous items. There is also a worksheet to
estimate start-up costs and another to document revenues or funding
for the program. There are 2 results worksheets. One summarizes
total program costs and the other incorporates revenues to generate
profit/loss estimates. Finally, there are 2 worksheets that represent
standardized and customized unit costs that are assigned to itemized
resources included in the preceding worksheets.
Incorporating the economic principles discussed above, the
TEAM-HF Costing Tool was developed as a Microsoft Excel
application to facilitate adoption by a diverse array of users for
numerous potential purposes (Table 1). The tool includes a user
manual and a separate Excel-based questionnaire in which the user’s
responses generate customized, printable forms to guide data collec-
tion. The TEAM-HF Costing Tool and associated documents will be
available for download from the Internet at no cost to the user
(http://www.team-hf.com/).
Description and Costing Options
The TEAM-HF Costing Tool was developed to estimate costs for 3
types of scenarios, based on (1) whether patients participate in a
given program for a fixed period of time or indefinitely and (2)
whether the user wishes to estimate costs for a fixed number of
patients (eg, a cohort of 100 patients) or per unit of time for a
program that continues to enroll new participants (eg, annual cost per
patient). Based on the type of program selected, the required inputs
vary (Table 2).
Personnel
Personnel typically account for the majority of costs in the provision
of behavioral or educational interventions. Personnel costs are
estimated using 1 of 2 methods: the top-down approach and the
bottom-up approach. With the top-down approach, users provide
estimates of weekly time associated with the program. With the
bottom-up approach, users provide estimates of time spent by each
type of personnel for each encounter (eg, face-to-face session,
telephone call).
Facility Costs
The “Facility Costs” worksheet is designed to estimate costs asso-
ciated with the physical locations required to provide the intervention
(eg, office space, clinic examination rooms). Users may choose to
estimate facility costs using 1 of 3 methods: (1) fixed percentage
based on personnel cost; (2) cost per square foot; and (3) an
“off-the-shelf” cost (Table 3). The off-the-shelf method is similar to
the cost-per-square-foot approach but uses standard estimates of
square footage for different types of facilities (eg, offices, examina-
tion rooms) to reduce user burden.
Equipment Costs
The “Equipment Costs” worksheet captures information on resources
used across multiple patients but not depleted during the delivery of
the program (eg, computers, software, office furniture). Costs for
equipment are amortized over time to represent the usable life of
each resource.
Table 1. Potential Uses of the TEAM-HF Costing Tool
Potential Uses Explanation
Budgeting The tool can assist in annual budgeting in terms of
estimating costs for specified numbers and types of
personnel, facilities, equipment, and other costs
necessary to provide a patient-centered intervention
Reimbursement
negotiations
The tool will allow the user to compare estimated costs
to deliver the program with reimbursement rates set by
a given insurance company. The user may use the cost
estimates generated with the tool to negotiate for
higher reimbursement rates
Improve efficiency
of an existing
program
The tool can be used to examine the cost impact of
various program changes, such shortening time spent
per encounter, increasing volume of patients enrolled to
allocate fixed costs (eg, facilities and equipment) over a
larger number of patients
Cost-effectiveness
evaluation
The tool can be used to compute the average cost (per
patient, per encounter) for the program that can be
used in a cost-effectiveness analysis designed to
evaluate whether the intervention provides good value
for money if other scientifically sound principles of
economic evaluation are followed
TEAM-HF indicates Tools for Economic Analysis of Patient Management
Interventions in Heart Failure.
Table 2. Three Types of Scenarios Modeled in the TEAM-HF Costing Tool
Scenario Type Description Example Inputs Required
Fixed duration
per patient,
single cohort
This scenario represents a program in which
a given number of patients are enrolled for
a fixed period of time or a fixed number of
“encounters”
Eight-week disease management
program for a cohort of 30
patients
Duration of program per patient
Number of patients per cohort
Fixed duration
per patient,
ongoing accrual
This scenario represents a program in which
individual patients are enrolled for a fixed
period of time or a fixed number of
“encounters,” and the program is continually
accruing new patients
Disease management program
that enrolls patients for an
8-week intervention after the
patient’s first hospitalization for
heart failure
Duration of program per patient
Total number of patients accrued in
the program over 1 year
Ongoing duration
per patient,
ongoing accrual
This scenario represents a program in which
patients continue participation for a
nonspecified duration and the program is
continually accruing new patients
Disease management program in
which patients participate until
they drop out or die
Total number of patients participating
in the program over 1 year
TEAM-HF indicates Tools for Economic Analysis of Patient Management Interventions in Heart Failure.
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Supplies and Incentives
The “Supplies and Incentives” worksheet captures information on
resources that are depleted during the delivery of the program.
Supplies represent items given to individual patients, such as
exercise equipment, medications or remote monitoring devices (eg,
digital scales, handheld personal digital assistants) or used in the
provision of services to individual patients (eg, education materials,
intravenous diuretics, disposable medical equipment). Information
on patient time and costs incurred by patients (eg, parking, transpor-
tation) can be accounted for in this worksheet.
Miscellaneous Costs
The “Miscellaneous Costs” worksheet is designed to capture costs
not directly associated with the number of individuals enrolled in the
program or the number of encounters. Miscellaneous costs can
include professional licensing fees, professional training and travel,
and other resources, such as subscriptions to medical journals for
staff involved in the program.
Start-Up Costs
Start-up costs represent personnel costs and other resources or
expenses incurred before the program is initiated. Start-up costs
could include costs associated with training personnel, developing
intervention materials, and advertising or other outreach activities
necessary to initiate the program. There is sometimes confusion
between equipment costs and start-up costs. For example, a software
program designed to monitor electronic devices for heart failure
patients may be considered to be a start-up cost. However, a
purchased program should be captured as an equipment cost to be
allocated across individuals participating in the program over its
expected duration of use.
Total Costs
The “Total Costs” worksheet provides tables summarizing resource-
specific and total costs on an annual and weekly basis for the
program as a whole and for each patient. Consistent with the other
worksheets, cost estimates are provided using standardized as well as
customized units in separate worksheets containing unit prices and
other assumptions (eg, fringe benefit rates) necessary for cost
estimation. The primary source for salary and benefit information in
the “Standardized Units” worksheet is the US Bureau of Labor
Statistics.33 Estimates regarding years of use for equipment were
obtained from the Internal Revenue Service.34
Pilot Testing
On development of the final draft of the costing tool, 4 individuals
participated in pilot testing: 3 from academic medical centers and 1
from a community setting. The participants were asked to complete
the costing tool for the disease management program they were
involved with or for a hypothetical disease management program.
We allowed for representation of a hypothetical program, because
our primary interest was in assessing ease of use and identifying
areas where further clarification or modifications were needed rather
than developing accurate cost estimates from 4 disparate programs.
To elicit structured feedback, we developed a short survey for
completion by each of the 4 individuals involved in pilot testing.
Results
All 4 individuals who participated in pilot testing completed
the written survey. Three of 4 reported using the data
collection forms. Two chose the “top-down” costing method
and 2 chose the “bottom-up” method to estimate personnel
costs. For estimating facility costs, all participants chose the
approach in which facility costs are based on a percentage of
personnel costs. Respondents agreed that the costing tool was
clear and well formatted and followed a logical order.
Comparison With Published Cost Estimates
To evaluate the extent to which the costing tool generates
valid and reliable cost estimates, we applied cost inputs and
assumptions recently reported in an economic evaluation of
Heart Failure: A Controlled Trial Investigating Outcomes of
Exercise Training (HF-ACTION), an exercise training pro-
gram for patients with heart failure.9 We compared the
estimates generated by the TEAM-HF Costing Tool with
estimates reported in the HF-ACTION economic evaluation.
The exercise training protocol prescribed 3 sessions per
patient per week across 12 weeks. Patients completed, on
average, 17.1 hours of exercise in 32.7 sessions, a mean of
31.4 minutes per session. In the HF-ACTION analysis,
trainers supervised an average of 1.7 patients per session and
spent an average of 35 minutes before and after each session
on associated activities, such as documentation in the medical
record, billing, and scheduling. Time was not explicitly
recorded for sessions when patients failed to arrive. Details
regarding salaries for exercise physiologists, facility space,
exercise equipment, and other assumptions necessary to
generate cost estimates were also reported in the online-only
Data Supplement Appendix.9
To generate costs using the TEAM-HF Costing Tool, we
selected the option representing the program type as a “fixed
duration per cohort–single cohort,” which is appropriate for
estimating costs in the setting of a clinical study (Figure). We
then populated corresponding cells to indicate that the pro-
gram duration of 12 weeks and the cohort size of 14,
consistent with the 1159 patients enrolled in the exercise
training arm distributed across 82 sites. To derive personnel
costs, we applied the “bottom-up” method, entering 66.4
minutes as the time spent by exercise physiologists for each
Table 3. Options for Estimating Costs for Facilities
Costing Strategy Description Inputs Required
Fixed percentage
based on personnel
cost
Costs for facilities are estimated as a fixed percentage of the total personnel
costs that are estimated using either the “top-down” or “bottom-up”
approaches for estimating personnel costs
None; estimates are based on personnel costs
“Cost-per-square-foot”
method
Costs for facilities are based on estimates of square feet used by the
program and the proportion of time the space is used by the program. This
method also provides an option for the user to apply an “add-on
percentage” to assign costs for utilities and other overhead costs
Estimates of square footage for each type of
space used by the program
Percentage of time the space is used to
deliver the program
“Off-the-shelf” method With this method, standardized estimates of square footage for each type of
space are applied. When using this method, costs for utilities and other
overhead are already included in the estimated facility costs
Number of each type of space required (eg, 2
offices, 1 examination room)
Percentage of time the space is used to
deliver the program
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encounter. Although the costing tool was not designed to
account for group sessions, we accounted for the number of
patients per session by dividing 42 sessions per week by 1.7.
Then, to account for the actual number of sessions completed
rather than prescribed, we multiplied by the ratio of com-
pleted to prescribed sessions (ie, 32.7/36). To value each of
the resources, we applied the standardized units included in
the costing tool and populated the “Customized Units”
spreadsheet to correspond to reported salaries, fringe benefit
rates, rental rates, and equipment costs.
In the HF-ACTION economic evaluation,9 the direct total
cost of supervised exercise training was estimated at $632 per
patient. Total costs for supervised exercise training generated
with the TEAM-HF Costing Tool were $675 using standard-
ized costs and assumptions built into the tool. However, when
we used the customizing features of the tool to apply unit
costs for salaries, fringe benefit rates, and other assumptions
consistent with the HF-ACTION analysis, the resulting cost
estimate was $634 per patient (Figure).
Discussion
As the health care system evolves to address the needs of
patients with chronic conditions, new care management
strategies are proliferating. Although most are patient-
centered, they are heterogeneous, differing with regard to the
focus of the intervention (eg, medication adherence, care
coordination, exercise training), the mode of delivery (eg,
home visits, telephone, remote monitoring), targeted patient
populations (eg, higher versus lower disease severity, low
income), frequency of contact, duration, and the types of
health care providers involved. Even among similar types of
programs, comparisons of program costs currently available
in the literature are nearly impossible given the lack of
methodological detail, the wide range of costing strategies
that could be applied, and variations in wage rates and other
costs across practice settings and geographic locations. To
promote the generation of high-quality cost estimates for
informed decision-making, we developed the TEAM-HF
Costing Tool for use by researchers, managers, and other
professionals throughout the health care system and demon-
strated its utility for computing costs associated with an
exercise training program.
The TEAM-HF Costing Tool can facilitate standardization
of unit costs and assumptions for estimating intervention
costs for application in cost-effectiveness analyses. However,
choices used in the generation of the cost estimates must be
consistent with economic principles underpinning the design
and execution of a cost-effectiveness analysis. The study
perspective and time horizon must be selected in accordance
with the intended audience for the analysis. With a societal
perspective, a long-term time horizon is typically appropriate,
and analysts should include all program-related resources
valued to approximate opportunity costs. To facilitate com-
parisons across separate studies, we recommend the standard-
ized units incorporated in the costing tool. When a provider or
payer perspective is chosen, the user would be advised to
apply customized units to generate meaningful and accurate
cost estimates. Also with regard to the use of cost estimates
from the costing tool, cost-effectiveness analyses can be
carried out as a program-level analysis or a patient-level
analysis. In a program-level analysis, aggregated estimates of
program costs would be paired with aggregate estimates of
clinical benefits relative to standard care. In a patient-level
analysis (eg, data from a randomized trial), disaggregated
Figure. Excerpt From the Tools for Economic Analysis of Patient Management Interventions in Heart Failure (TEAM-HF) Costing
Tool and Comparison of findings with published estimates from Heart Failure: A Controlled Trial Investigating Outcomes of Exer-
cise Training (HF-ACTION). NYHA indicates New York Heart Association.
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estimates of program costs, such as the estimated cost per
patient per week, could be applied to each patient based on
the number of weeks of participation in the program. Another
benefit of the costing tool from a research perspective is that
use of standardized unit costs for salaries, facilities, and other
resources allows individual programs to publish study results
while avoiding public disclosure of confidential cost infor-
mation. Finally, the availability of the tool promotes full
reporting of methodological approaches and assumptions
applied in specific analyses, thereby allowing readers to
determine whether “apples-to-apples” comparisons are
possible.
In addition to developing the TEAM-HF Costing Tool to
facilitate standardization of costing methods for use in eco-
nomic evaluations, we recognized the need for a flexible tool
that could serve multiple potential uses for health care
managers. To inform budgetary decisions, health care man-
agers can use the “Customized Units” spreadsheet to enter
salaries and benefits paid to employees, rental rates, supply
costs, and other units to generate cost estimates for the
specific program at their site. Similarly, because the costing
principles integrated into the tool are generally accepted
across countries, individuals outside the United States could
modify the inputs in the “Customized Units” worksheet to
generate local cost estimates for a given program.
Wide adoption of the TEAM-HF Costing Tool would lead
to collection of cost estimates across patient-focused pro-
grams. Since the development of the Drug Abuse Treatment
Cost Analysis Program (DATCAP) in early 1990s,35 the tool
has been used by more than 110 programs to estimate costs
for a range of treatment programs including prison-based,
residential, and outpatient programs.36 This compilation of
cost estimates allowed for publication of a set of cost bands
for 8 treatment modalities to facilitate funding and reimburse-
ment decisions for substance abuse treatment.36 With adop-
tion of the TEAM-HF Costing Tool across a variety of users
and dissemination of the resulting cost estimates, similar cost
bands could be developed for specific types of patient-
focused interventions in heart failure or other conditions.
Limitations
Although we aimed to develop a user-friendly costing system
that is both flexible and comprehensive, we cannot anticipate
all user needs. As mentioned previously, it is important to
recognize that the system is not designed to evaluate the
impact of programs on medical costs stemming from reduced
rehospitalization rates or other clinical outcomes. However,
we are in the process of developing another TEAM-HF tool
to evaluate the cost-effectiveness of patient-focused programs
specifically targeting patients with heart failure. This tool will
incorporate changes resulting from an intervention on pa-
tients’ clinical and treatment characteristics to project down-
stream consequences on costs and quality-adjusted survival.
In addition, although we believe that incorporating standard-
ized unit costs into the TEAM-HF Costing Tool offers an
advantage over costing systems developed for other uses, no
one set of standardized units will be appropriate for all
programs. For example, standardized unit costs for supplies
such as blood pressure cuffs may reflect costs incurred across
a wide range of practices, whereas salaries for personnel may
vary across locations and settings. As the costing tool is
adopted, we expect that users will point out which standard-
ized units are inappropriate and have a meaningful impact on
estimated program costs. As this information becomes avail-
able, future versions of the costing tool could be updated to
incorporate more suitable inputs. Also, unit costs will require
updating over time. We anticipate incorporating unit costs for
future years and allowing the user to simply select from a list
representing years for which standardized unit costs are
available.
We believe that researchers or program managers can
successfully complete the costing tool with the information
available in the user manual. The amount of time required
will depend on the user’s choice to use the standardized or
customized unit costs, the costing methods selected, and the
availability of information about the size of the program and
provider time spent on associated activities. Feedback from
our pilot study suggests that a guided introduction to the
TEAM-HF Costing Tool would positively influence the
extent to which it is adopted by users. To promote its use, we
are planning to provide training seminars at regional and
national professional meetings and to develop online training
videos that will be available when individuals are ready to
begin using the tool. Last, we encourage individuals to visit
the TEAM-HF Web site for the costing tool and associated
documentation (http://www.team-hf.com/).
Conclusions
The TEAM-HF Costing Tool can assist researchers and
health care managers in the generation of high-quality,
comprehensive cost estimates of patient-centered interven-
tions that can be applied in economic evaluations and
facilitate well-informed decision making for internal budget-
ing, program planning, reimbursement negotiations, and im-
proving the efficiency of existing programs.
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